Safety Study of Rituximab (Rituxan®) in Chronic Urticaria

NCT00216762 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Full Clinical Hold

Conditions

Urticaria

Interventions

DRUG: Rituximab

Sponsor

Johns Hopkins University

Collaborators

[object Object]